About Kinvan
Kinvan is a Healthcare company based in India. It manufactures fermentation-based pharmaceutical products for antibiotic resistance. It operates on a B2B model. The company has 301 employees. Its Indian entity Kinvan Private Limited reported revenue of ₹136 Cr. Kinvan offers products and services including AVICIL Stabilised Potassium Clavulanate, SiO2 Stabilised Potassium Clavulanate, and Potassium Clavulanate + Amoxycillin (1:5). Its focus areas include Pharmaceuticals, Active Pharmaceutical Ingredients, Fermentation Manufacturing and Biotechnology.
Company details
Kinvan Private Limited, incorporated in 2020, produces Clavulanic Acid through fermentation processes as part of Indias Production Linked Incentive Scheme. It focuses on key starting materials and active pharmaceutical ingredients for overcoming bacterial resistance in antibiotics. The company operates from its manufacturing facility in Nalagarh, Himachal Pradesh, and registered office in Mumbai, supplying to the pharmaceutical industry with a commitment to domestic production.
- Headquarters India
- Employees 301
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website kinvan.co.in
- Legal Name Kinvan Private Limited
- Date of Incorporation 10 Oct, 2020
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹136 Cr
FY 2025 · +11959% YoY
- Net Loss-₹47.35 Cr
FY 2025 · -35% margin
- EBITDA₹26.80 Cr
FY 2025 · 20% margin
- Employee Count301
Associated legal entities of Kinvan
Kinvan is associated with 2 registered companies on The Company Check; the primary company is Kinvan Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Kinvan Private Limited CIN U24100HP2020PTC011851 | Active | 10 Oct 2020 | Solan, Himachal Pradesh | ₹136 Cr | 301 | 3 | View details |
| Kinvan Private Limited CIN U24100MH2020PTC347604 | – | 10 Oct 2020 | Mumbai, Maharashtra, India | – | – | – | View details |
Products & Services of Kinvan
Kinvan offers a comprehensive portfolio of products and services, including AVICIL Stabilised Potassium Clavulanate, SiO2 Stabilised Potassium Clavulanate, and Potassium Clavulanate + Amoxycillin (1:5).
Inhibits beta-lactamase to enhance penicillin effectiveness against bacteria.
Stabilizes Clavulanate for use in pharmaceutical formulations.
Combines with Amoxycillin to treat resistant bacterial infections.
Board of directors of Kinvan Private Limited (Kinvan)
Kinvan Private Limited is the primary company behind Kinvan. The board of Kinvan Private Limited currently have 2 directors; the longest-serving is Devang Manharlal Ajmera, appointed in 2020. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Devang Manharlal Ajmera DIN 02366861 | Director | 10 Oct 2020 | 6 yrs | Kinvan Private Limited |
| Sahebrao Sukhdeo Khilari DIN 02740227 | Director | 10 Nov 2021 | 4 yrs 11 mo | Kinvan Private Limited |
Financials of Kinvan
Figures of Kinvan Private Limited, the primary company behind Kinvan, for FY 2025. Revenue was ₹136 Cr (+11959% year on year). Net loss was -₹47.35 Cr (-35% margin). EBITDA was ₹26.80 Cr (20% margin).
- ₹136 CrRevenue · FY 2025 · +11959% YoY
- -₹47.35 CrNet loss · -35% margin
- ₹26.80 CrEBITDA · 20% margin
- ₹224 CrPaid-up capital
- 301Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Kinvan Private Limited are on its company page.
Detailed financial statements for Kinvan
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Kinvan (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Kinvan
Kinvan is headquartered in India.
Kinvan has 301 employees.
The primary company behind Kinvan, Kinvan Private Limited, reported revenue of ₹136 Cr for FY 2025, up 11959% year on year.
Kinvan Private Limited, incorporated in 2020, produces Clavulanic Acid through fermentation processes as part of Indias Production Linked Incentive Scheme. It focuses on key starting materials and active pharmaceutical ingredients for overcoming bacterial resistance in antibiotics. The company operates from its manufacturing facility in Nalagarh, Himachal Pradesh, and registered office in Mumbai, supplying to the pharmaceutical industry with a commitment to domestic production.
Kinvan offers AVICIL Stabilised Potassium Clavulanate, SiO2 Stabilised Potassium Clavulanate, and Potassium Clavulanate + Amoxycillin (1:5).
Kinvan operates through Kinvan Private Limited.
The legal entities of Kinvan currently have 3 directors, including Devang Manharlal Ajmera, Sahebrao Sukhdeo Khilari, Neha Suresh Khandelwal.